Malin Hultcrantz MD, PhD

Dr. Malin Hultcrantz is an Associate Attending, Associate Professor who specializes in the treatment of multiple myeloma and related plasma cell disorders. Dr. Hultcrantz has extensive experience in epidemiological research in multiple myeloma and the precursor disorders MGUS and smoldering multiple myeloma. Dr. Hultcrantz is leading multiple trials focused on novel immunotherapies as well as studies to improve minimal residual disease (MRD) testing.